ACRVVSBJDX• 28 Days (Normalized)
ACRV vs BJDX (Acrivon Therapeutics Inc. vs Bluejay Diagnostics Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
-28.87%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BJDX Performance $0.81
-15.31%
Bluejay Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BJDX LEADS
-13.56%
BJDX outperforming by 13.56%
ACRVBJDX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BJDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ACRV Price | ACRV Gain (%) | BJDX Price | BJDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | -28.87% | $0.81 | -15.31% | -13.56% |
| Sep 15, 2026 | $1.83 | -23.43% | $0.85 | -11.67% | -11.76% |
| Sep 14, 2026 | $1.96 | -17.99% | $0.85 | -11.46% | -6.53% |
| Sep 11, 2026 | $2.00 | -16.32% | $0.90 | -6.56% | -9.76% |
| Sep 10, 2026 | $2.04 | -14.64% | $1.01 | +5.21% | -19.85% |
| Sep 09, 2026 | $1.99 | -16.74% | $1.01 | +5.21% | -21.95% |
| Sep 08, 2026 | $2.10 | -12.13% | $1.03 | +7.29% | -19.42% |
| Sep 04, 2026 | $2.13 | -10.88% | $0.83 | -13.33% | +2.45% |
| Sep 03, 2026 | $2.06 | -13.81% | $0.85 | -11.56% | -2.25% |
| Sep 02, 2026 | $2.15 | -10.04% | $0.85 | -11.56% | +1.52% |
| Sep 01, 2026 | $2.07 | -13.39% | $0.85 | -11.67% | -1.72% |
| Aug 31, 2026 | $2.09 | -12.55% | $0.87 | -9.37% | -3.18% |
| Aug 28, 2026 | $2.06 | -13.81% | $0.90 | -6.25% | -7.56% |
| Aug 27, 2026 | $2.15 | -10.04% | $0.91 | -5.21% | -4.83% |
| Aug 26, 2026 | $2.08 | -12.97% | $0.89 | -6.98% | -5.99% |
Page 1 of 2